Brief: Anebulo Pharmaceuticals Reports Q2 Loss Of $0.15 Per Share
Feb 10 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS REPORTS SECOND QUARTER FISCAL YEAR
2023
FINANCIAL RESULTS AND RECENT UPDATES
* NET LOSS IN Q2 OF FISCAL 2023 WAS $0.15 PER SHARE
* Q2 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
* CASH WAS $16.4 MILLION AS OF DECEMBER 31, 2022
Source text for Eikon: ID:nBw9YQ8Xfa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results